Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Webinar | Biosimilars – 2019 Mid-Year Update

Thursday, July 18th, 2019, 1:00 pm EDT

Webinar | Biosimilars – 2019 Mid-Year Update

This webinar took place on: Thursday, July 18th, 2019, 1:00 pm EDT

This webinar has ended.

On July 18, please join life sciences attorneys John Adkisson, Tasha Francis, and Jenny Shmuel, who will provide a mid-year review on the current status of the U.S. biosimilars space. Topics to be discussed include recent developments regarding:

  • The U.S. biosimilars market: approvals, launches, and anticipated launches
  • FDA guidance
  • Select court cases and appellate guidance
  • Trends in IPRs in the biosimilars space
  • What’s on the horizon for biosimilars

Recent legislative proposals with potential impact on the biosimilars market will also be reviewed. Be sure to register at the link below to remain current on developments in the rapidly-evolving U.S. biosimilars market.

Thursday, July 18
1:00-2:00 PM EDT

This program is designed for and open to all attorneys. If you have questions, please contact Jane Lundberg at [email protected].

Fish & Richardson, P.C., is an accredited CLE provider by the California, New York, and Texas State Continuing Legal Education Boards. (California Provider Number 4933) Fish & Richardson will apply for 1.0 hour of CLE credit in some additional states. Credit will be awarded only to attorneys who report their required CLE states during the registration process and who log in and complete the webinar in its entirety. Note that Fish is unable to grant CLE credit to attendees who listen to the audio portion only.